SYBXOTCPharmaceutical PreparationsFiscal year ends December 31
SYNLOGIC, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$1.07+0.07 (+7.00%)
Close on Oct 19, 2026
- Market cap
- $13.29M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.76 (−41.53%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
SYNLOGIC, INC. reported revenue of $0 for the twelve months to Jun 30, 2026. Free cash flow was -$4.36M.
Revenue
$0
TTM Q2 2026
Operating income
-$4.66M
TTM Q2 2026
Free cash flow
-$4.36M
FY2025
EPS, diluted
-$0.06
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $13.29M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.11
- Dividend yield
- –
- Free cash flow yield
- -32.80%
Fundamentals
- Revenue
- $0
- Net income
- -$655.00K
- EPS, diluted
- -$0.06
- Free cash flow
- -$4.36M
- Book value per share
- $0.97
- Diluted shares
- 12M
Fourteen years at a glance
Fiscal years 2012 to 2025 and trailing twelve months, USD
Revenue
$0
Operating income
-$4.66M
Net income
-$655.00K
EPS, diluted
-$0.06
Free cash flow
–
Reported periodTrailing twelve months